Born in 1952 B.Sc. in Economics, University of Copenhagen.
Profession: Independent Advisor, Consultant and Board Member. Chairman of the Board in Atlas Antibodies AB and Genovis AB. Board Member of Micropos Medical AB and Advanced Instruments Inc.
Born in 1967
MBA Stockholm School of Economics.
Profession: Independent Advisor, Consultant and Board Member.
Chairman of the Board of Sedana Medical AB, Immedica AB and Mabtech AB. Board member of Boule Diagnostics AB, Bioworks AB and Surgical Science AB.
Born in 1956
Ph.D. in Medical Chemstry, Uppsala University.
Profession: Managing Director-
Board Member of Pepticore and Red Glead Discovery.
Born in 1955
M.Sc. Mechanical Engineering, Royal Institute of Technology, Stockholm. Management studies at IHM, Stockholm.
Chairman of the Board of Boule Diagnostics AB, Medcap AB, Bioworks Technologies AB, Sophion A/S, Grönsöö Säteri AB and Färjsundet Industri AB.
Born in 1962
PhD. University of Oxford.
Other Assignments: Academic
Born in 1962
Education: Master of Science in Biophysics University of Minnesota, U.S.A.
Bachelors degree in Physics Gustavus Adolphus College, U.S.A.
Occupation: Board member, Investor.
Other assignments: Nolato AB, Tobii AB, Cellavision AB, C-Rad AB, E Öhman Fonder AB, Industrifonden and Artificial Solutions.
Born in 1977
Ph.D. in Chemistry, University of South Carolina
Profession: Global Product Manager, Analytical
Employee Since: 2015
The Board of Directors is ultimately responsible for the management and the organization of the Company. The board of directors shall consist of no fewer than five and no more than nine directors elected by a General Meeting of shareholders. Swedish law allow for the relevant trade unions to appoint two Directors and two Deputy Directors.
The Directors are appointed at the Annual General Meeting for a period of one year, i.e. up and until the next Annual General Meeting. Any vacancy in the Board of Directors may only be replaced through a resolution passed by the shareholders. The trade unions representing the employees at the Company may decide the term of the seat for their Board of Director representatives. The term for the employee representatives may, however, not exceed four years, but each such term may be prolonged without any limitation.
The Annual General Meeting held on April 28, 2021, resolved to re-elect Thomas Eklund, Karolina Lawitz, Peter Ehrenheim, Mark Bradley, Torben Jörgensen, Åsa Hedin as Directors of the Board of Directors.
Employee representative is Dan Menasco (deputy).
The Annual General Meeting appointed Torben Jörgensen as Chairman of the Board of Directors.
The Annual General Meeting 2021 resolved that a fixed fee, including fees for work in committees, of SEK 2,345,000 shall be paid to the Board of Directors for the period up to and including the Annual General Meeting 2021 to be distributed as follows. The Chairman shall receive SEK 675,000 and each of the other board members elected by the Annual General Meeting who are not employed by the company shall receive SEK 280,000. Furthermore, a fee shall be paid to the members of the Auditing Committee of an aggregate of not more than SEK 160,000, whereof the chairman shall receive SEK 90,000 and the two other members SEK 35,000 each, and a fee shall be paid to the members of the compensation committee of an aggregate of not more than SEK
110,000 whereof the chairman shall receive SEK 60,000 and the other two members SEK 25,000 each.
The work of the Board of Directors is governed by Rules of Procedure for the Board of Directors. These rules are reviewed at least once per year and then re-adopted by the Board of Directors. The Rules of Procedure for the Board of Directors is principally made up of guidelines for how the Board of Director shall carry out their duties, instructions for how to divide the responsibilities between the Board of Directors and the CEO and instructions for the Company’s financial reporting.